Men da det ene af de to positive resultater fire uger efter første injektion og før anden injektion optrådte hos en patient, der forinden var blevet behandlet med Botox, og da undersøgelsen stadig er blindet, kan der ikke heraf drages konklusioner om immunogeniciteten af Xeomin.
However, as one of the two positive results four weeks after 1st injection and before 2nd injection was found in a patient pretreated with Botox and the study is still blinded, no conclusions concerning immunogenicity of Xeomin can be drawn from these results.